These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7925963)

  • 1. Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit.
    Mitterdorfer J; Froschmayr M; Grabner M; Striessnig J; Glossmann H
    FEBS Lett; 1994 Sep; 352(2):141-5. PubMed ID: 7925963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.
    Mitterdorfer J; Sinnegger MJ; Grabner M; Striessnig J; Glossmann H
    Biochemistry; 1995 Jul; 34(29):9350-5. PubMed ID: 7626604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of cardiac Ca2+ channel pharmacology. Subunit requirement for the high affinity and allosteric regulation of dihydropyridine binding.
    Wei X; Pan S; Lang W; Kim H; Schneider T; Perez-Reyes E; Birnbaumer L
    J Biol Chem; 1995 Nov; 270(45):27106-11. PubMed ID: 7592963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
    Suh-Kim H; Wei X; Birnbaumer L
    Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding.
    Peterson BZ; Catterall WA
    J Biol Chem; 1995 Aug; 270(31):18201-4. PubMed ID: 7629136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable co-expression of calcium channel alpha 1, beta and alpha 2/delta subunits in a somatic cell line.
    Welling A; Bosse E; Cavalié A; Bottlender R; Ludwig A; Nastainczyk W; Flockerzi V; Hofmann F
    J Physiol; 1993 Nov; 471():749-65. PubMed ID: 8120832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel.
    Hockerman GH; Peterson BZ; Sharp E; Tanada TN; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14906-11. PubMed ID: 9405712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fura-2 imaging and electrophysiological analysis of murine calcium channel alpha 1 subunits coexpressed with novel beta 2 subunit isoforms.
    Massa E; Kelly KM; Yule DI; MacDonald RL; Uhler MD
    Mol Pharmacol; 1995 Apr; 47(4):707-16. PubMed ID: 7723731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel.
    Varadi G; Lory P; Schultz D; Varadi M; Schwartz A
    Nature; 1991 Jul; 352(6331):159-62. PubMed ID: 1712427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site.
    Kwan YW; Bangalore R; Lakitsh M; Glossmann H; Kass RS
    J Mol Cell Cardiol; 1995 Jan; 27(1):253-62. PubMed ID: 7760349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine binding and Ca(2+)-channel characterization in clonal calcitonin-secreting cells.
    Krautwurst D; Scherübl H; Kleppisch T; Hescheler J; Schultz G
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):659-65. PubMed ID: 8382045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels.
    Peterson BZ; Tanada TN; Catterall WA
    J Biol Chem; 1996 Mar; 271(10):5293-6. PubMed ID: 8621376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyridine binding of the calcium channel complex from skeletal muscle is modulated by subunit interaction.
    Woscholski R; Marmé D
    Cell Signal; 1992 Mar; 4(2):209-18. PubMed ID: 1319724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study.
    He M; Bodi I; Mikala G; Schwartz A
    J Biol Chem; 1997 Jan; 272(5):2629-33. PubMed ID: 9006896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of dihydropyridine (DHP) binding sites on cultured monkey renal cells (GMRC) with a photoaffinity probe (-)-[3H]-azidopine.
    Drímal J
    Gen Physiol Biophys; 1994 Apr; 13(2):137-48. PubMed ID: 7528701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors.
    Boer R; Grassegger A; Schudt C; Glossmann H
    Eur J Pharmacol; 1989 May; 172(2):131-45. PubMed ID: 2548881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.